U.S. Life Sciences Stock News

BellRing Brands stock has had a tough run over the past year, yet the current valuation checks suggest the shares may now be pricing in a lot of that weakness. Over the last 12 months, BellRing Brands has declined 79.2%, which puts a sharp reset in expectations front and center for any valuation view. Investors now have to weigh a leadership change, with Michael C. Axelrod taking over as CEO, against the overhang from a securities lawsuit that questions how past sales trends were...

Willis Towers Watson stock has delivered a 39.3% total return over the past 5 years, yet the current valuation picture is split, with the Excess Returns intrinsic value estimate pointing to upside while market multiples lean the other way. A 39.3% return over 5 years suggests Willis Towers Watson has rewarded patient shareholders, even though shorter term performance has recently been more subdued. Expansion in areas like cyber insurance and digital asset coverage can support growth...

LCI Industries stock is down about 18% year to date, yet both its Discounted Cash Flow (DCF) intrinsic value estimate and market multiples currently point to the shares trading at a discount. This sits against the backdrop of a planned all stock merger with Patrick Industries that will eventually swap each LCI share into Patrick stock. With the share price down 18% so far this year, the current valuation is being set by a market that has turned more cautious on LCI Industries despite a...

Kite Realty Group Trust (NYSE:KRG) was removed from the Russell 2000 Dynamic Index in late June 2026, a change that can affect how index-tracking funds allocate capital to the stock. This index removal brings passive ownership and liquidity into sharper focus for Kite Realty Group, adding a new layer of consideration to its existing retail REIT thesis. We will now examine how Kite Realty Group’s exit from the Russell 2000 Dynamic Index may influence its existing investment narrative and risk...

In late June 2026, Alto Ingredients, Inc. was added to multiple Russell equity and value indexes, including the Russell 2000, Russell 3000, Russell 2500, and related microcap and value benchmarks, while also partnering on a US$16 million Illinois River infrastructure project to enhance barge-based product transport and storage. This combination of broader index inclusion and investment in river logistics infrastructure highlights Alto Ingredients’ growing institutional visibility and efforts...

Big pharma is funding a field it once dismissed. These three psychedelic stocks carry possible clinical catalysts as the healthcare industry turns to alternative medicines.

Billions in prepaid spending flow through this corner of the market every year. Here are three US small-cap stocks positioned to capture it.

In late June 2026, BioAge Labs, Inc. (NasdaqGS:BIOA) was added to multiple Russell Growth Benchmark Indexes, including the Russell 2000, Russell 2500, Russell 3000, Russell 3000E, Russell Microcap, and the Russell Small Cap Comp Growth indexes. This broad index inclusion significantly expands BioAge Labs’ visibility among institutional investors and index-tracking funds that follow these Russell Growth benchmarks. Next, we’ll examine how BioAge Labs’ broad Russell Growth index inclusion...

Tariff headlines are back in focus, and this time the pressure is squarely on import costs for U.S. consumers and businesses. With Virginia and other states pushing back against broad U.S. tariffs, investors are weighing what heavier trade frictions and higher prices could mean for different parts of the market. Domestic focused stocks that rely less on imported inputs can appear relatively insulated when trade tensions rise, while others may face higher cost pressure or sentiment swings...

In recent days, First Industrial Realty Trust reported strong Q1 2026 results, with earnings per share of US$1.08 significantly exceeding forecasts, and attracted renewed coverage from several investment firms highlighting demand for its logistics properties. This combination of outperformance against expectations and fresh analyst attention has sharpened the focus on how First Industrial is positioned within the industrial real estate market. With Q1 earnings materially ahead of forecasts,...

Pure Cycle (PCYO) has posted its Q3 2026 numbers with total revenue of about US$8.2 million and basic EPS of US$0.12, set against trailing twelve month revenue of roughly US$33.7 million and EPS of US$0.61, underpinned by 8.2% earnings growth over the past year. Over recent quarters, the company has seen revenue move from around US$5.2 million with EPS of US$0.03 in Q2 2025 to US$11.2 million with EPS of US$0.25 in Q4 2025, then to US$8.2 million and EPS of US$0.12 in Q3 2026. This has left...

Butler National (BUKS) has put up a clean set of FY 2026 numbers, with fourth quarter revenue at US$27.7 million and basic EPS of US$0.09, alongside trailing twelve month revenue of US$98.0 million and EPS of US$0.34 that sit against reported earnings growth of 74.8% over the past year. Over recent periods the company has seen revenue progress from US$83.97 million on a trailing basis in FY 2025 to US$98.0 million in FY 2026. EPS over the same trailing window moved from US$0.19 to US$0.34,...

Wayfair's share price has rebounded in the last year, but with the stock still down 68.5% over five years and screening as overvalued on market multiples, the current level raises questions about how much of the recovery story is already reflected in the price. Over the past five years, Wayfair has delivered a total return that is down 68.5%, which highlights how deep the earlier drawdown was despite the more recent strength. Recent optimism around improving earnings expectations can support...

PriceSmart (PSMT) has released its Q3 2026 results, reporting revenue of about US$1.5b, basic EPS of roughly US$1.31 and net income, excluding extra items, of US$39.7m. The company’s quarterly revenue has moved from US$1.33b in Q4 2025 to US$1.38b in Q1 2026, US$1.50b in Q2 2026 and US$1.48b in Q3 2026. Over the same period, basic EPS ranged from US$1.02 to US$1.62, giving investors a clear view of top line scale and earnings power to track. With trailing 12 month EPS of about US$5.22 and a...

Arbutus Biopharma stock has delivered a strong 126.4% return over the past three years, yet its current valuation checks and market multiples suggest the shares are not a clear bargain at recent levels. Over the last three years, Arbutus Biopharma has returned 126.4%, which puts extra focus on whether the current share price already reflects much of the good news investors are hoping for. Expectations around the company’s ability to turn its pipeline and research into durable cash flows can...

AZZ (AZZ) has opened fiscal 2027 with Q1 revenue of $448.5 million and basic EPS of $1.74, setting the tone for how its earnings story is evolving after a mixed year of growth and margin shifts. The company has seen quarterly revenue move from $421.9 million and EPS of $5.71 in Q1 2026 to $448.5 million and $1.74 in Q1 2027, against a backdrop where trailing 12 month EPS was $6.62 and net income was $198.4 million. This frames a results season in which investors are watching how profit...

Helen of Troy (HELE) opened fiscal Q1 2027 with revenue of US$402.1 million and basic EPS of US$1.54, while the trailing twelve months show revenue of US$1.8 billion and a basic EPS loss of US$17.87, highlighting the gap between the latest quarter and the broader period. Over the past few reported quarters, revenue has ranged from US$371.7 million to US$512.8 million and EPS has swung from a loss of US$19.65 to a profit of US$2.22. This sets the backdrop for how investors read this latest...

With major indexes riding an AI-fueled surge and the Buffett indicator sitting at a very high level relative to GDP, many investors are wondering where genuine value still exists and where risks might be building. This article looks at how that backdrop could affect a group of stocks flagged by a Value Stocks screener, focusing on low P/E and P/B ratios and a possible discount to intrinsic value. Below, you will find 3 stocks that the recent market setup may treat as relative beneficiaries...

In recent months, AllianceBernstein Holding has advanced efforts to lift profitability through office relocations and other margin accretion measures, while broadening its private markets platform via partnerships and new products in private credit, real estate, and alternative strategies. This push into higher-fee private markets and operational efficiency has sharpened investor focus on how the firm may reshape its earnings mix and risk profile. Next, we’ll examine how AllianceBernstein’s...

Microchip Technology has made its MPLAB XC Pro Compilers and Machine Learning Development Suite available for free to all users worldwide. The move also covers its functional safety compilers, broadening access to tools for safety-critical and AI-enabled embedded applications. This shift is expected to widen adoption of Microchip’s microcontroller platforms and deepen engagement with its development ecosystem. For investors watching NasdaqGS:MCHP, this software decision adds an important...

After a strong first month as a public company, Quantinuum’s near 30% gain over the past 30 days sits alongside a sharp split in valuation signals, with a Discounted Cash Flow (DCF) intrinsic value estimate pointing to meaningful upside while market based multiples screen the stock as expensive. The question for investors is how to weigh that tension against early stage quantum computing expectations and the stock’s low overall value score. Quantinuum has risen 29.5% over the past month,...

Prologis (NYSE:PLD) has taken its proposed all stock combination with SEGRO public, releasing a new presentation to SEGRO shareholders. The company is urging SEGRO investors to press their board to enter takeover talks, while SEGRO's board continues to resist the deal. This move shifts the discussion from private boardroom talks to a wider shareholder audience, highlighting Prologis' commitment to a public engagement campaign. Prologis enters this phase of the saga with its stock at $141.0...

Pagaya Technologies and Upgrade have expanded their partnership to bring Pagaya’s AI-driven credit decisioning to Buy Now, Pay Later offerings. The collaboration targets BNPL solutions for travel merchants, broadening Pagaya’s reach beyond personal loans. The development highlights a move into new asset classes for Pagaya’s platform, with potential implications for its client mix and revenue sources. Pagaya Technologies (NasdaqCM:PGY) is drawing fresh attention as it extends its AI credit...

Southwest Airlines and Korean carrier Air Premia have entered into their first-ever interline partnership. The agreement connects Air Premia routes from South Korea with more than 120 destinations across the Southwest Airlines network. The partnership opens new East Asia connectivity for Southwest customers and expands options for travelers originating in South Korea. For investors watching Southwest Airlines, ticker NYSE:LUV, this partnership introduces an additional international angle to...